Opioid Use Disorder Market Size, Share & Growth by 2034

Coverage: By Drug Type (Buprenorphine, Methadone, Naltrexone) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00006732
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : April 09, 2026
Opioid Use Disorder Market Size, Share & Growth by 2034
Report Date: April 09, 2026   |   Report Code: TIPRE00006732 Email: sales@theinsightpartners.com

2025 Market Size

US$ 6.03 Bn

Base year value

2034 Forecast

US$ 15.63 Bn

Projected by 2034

CAGR 2026-2034

11.16 %

Growth rate

Addressable Market

US$ 95.58 Bn

(2026-2034)

Opioid Use Disorder market size is expected to reach US$ 15.63 Billion by 2034 from US$ 6.03 Billion in 2025. The market is anticipated to register a CAGR of 11.16% during the forecast period 2026–2034.

The Opioid Use Disorder Market report covers analysis by Drug Type (Buprenorphine, Methadone, Naltrexone), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.

Purpose of the Report

The report Opioid Use Disorder Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Opioid Use Disorder Market Segmentation Drug Type

  1. Buprenorphine
  2. Methadone
  3. Naltrexone

Market Assessment and Insights

  • Global market for Opioid Use Disorder was valued at US$ 6.03 Billion in 2025
  • Annual market size is expected to reach US$ 15.63 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 95.58 Billion
  • Market is anticipated to register a CAGR of 11.16% during the forecast period
  • The United States represents a key market, supported by Increasing Prevalence of Opioid Addiction, Government Initiatives and Regulatory Support, Development of new drugs, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Development of Non-Addictive Medications, Collaborations and Partnerships, Advances in Genetics and Biomarkers are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • ● Segmentations
  • ● Geography
  • ● Competitive Analysis
  • ● Language Preferences

Opioid Use Disorder Market: Strategic Insights

opioid-use-disorder-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Opioid Use Disorder Market Growth Drivers

  1. Increasing Prevalence of Opioid Addiction: Opioid addiction has increased worldwide due to both prescription opioid misuse and the growing availability of illicit opioids, including heroin and synthetic opioids like fentanyl. The epidemic has driven a surge in demand for effective treatment options to manage withdrawal symptoms and reduce dependency, thereby driving market growth for OUD treatments.
  2. Government Initiatives and Regulatory Support: Governments of the world are now acknowledging the crisis of opioids to be a health emergency and initiating various measures such as financing treatment programs, regulatory changes for making medication-assisted treatment (MAT) more accessible to patients, and reducing the issuance of prescriptions related to opioids. All these developments are further fostering investment in the OUD treatment market.
  3. Development of new drugs: Pharmaceutical companies are now investing in new therapies. New developments include the long-acting release, non-opioid, and opioid-receptor therapies given through novel methods. These changes improve the treatments, bring new treatments for better patient care, challenge each other, and make the industry grow.

Opioid Use Disorder Market Future Trends

  1. Shift Towards Holistic and Comprehensive Treatment Models: There is an increasing recognition that OUD needs a multi-faceted treatment approach that incorporates pharmacological treatments with behavioral therapy and support systems. These holistic models address both the physical and psychological aspects of addiction, thereby improving overall treatment success rates and driving market demand for a variety of therapeutic options.
  2. Digital Therapeutics: Mobile applications and telehealth platforms are increasingly being used to provide remote support, track patient progress, and deliver therapy sessions. Such technologies promote more engagements and accessibility, which can now reach more unrepresented geographical areas, opening new avenues for growth in the OUD treatment market.
  3. Long-acting formulations: These will include long-acting injectables and implants. The advantages of these will be improved compliance, reduced risk of misuse, and sustained therapeutic effects. These will make long-acting formulations attractive to both patients and healthcare providers, accelerating their adoption as well as increasing market growth.

Opioid Use Disorder Market Opportunities

  1. Development of Non-Addictive Medications: There is a significant need for non-addictive medications regarding the treatment of pain and OUDs. Companies that continue to put more investment into the development of alternatives will eventually capture a huge market share due to the growing demand for safer options.
  2. Collaborations and Partnerships: Collaborations between pharmaceutical companies, healthcare providers, and the government will ensure that OUD solutions are holistic. It allows for innovation and increases accessibility to care, makes the regulatory approval process more streamlined, and can create mutual benefits and market growth.
  3. Advances in Genetics and Biomarkers: Understanding the genetic and biological factors that predispose individuals to OUD can lead to the development of targeted therapies and preventative measures. Research in this area presents opportunities for the creation of personalized treatments that can improve patient outcomes and expand the market.

Opioid Use Disorder Market Report Scope

Report Attribute Details
Market size in 2025 US$ 6.03 Billion
Market Size by 2034 US$ 15.63 Billion
Global CAGR (2026 - 2034) 11.16%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Drug Type
  • Buprenorphine
  • Methadone
  • Naltrexone
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Indivior
  • Alkermes
  • Titan Pharmaceuticals
  • Hikma Pharmaceuticals
  • Teva Pharmaceuticals
  • MediciNova
  • Orexo
  • Camurus
  • Omeros

Opioid Use Disorder Market Players Density: Understanding Its Impact on Business Dynamics

The Opioid Use Disorder Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

opioid-use-disorder-market-cagr

Key Selling Points
  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Opioid Use Disorder Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Opioid Use Disorder Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

The major factors driving the Opioid Use Disorder Market are Increasing Prevalence of Opioid Addiction, Government Initiatives and Regulatory Support, and Development of new drugs

The key future trends of the market are Shift Towards Holistic and Comprehensive Treatment Models, Digital Therapeutics, and Long-acting formulations

The leading players operating in the Opioid Use Disorder Market include Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Some of the customization options available based on the request are an additional 35 company profiles and country-specific analysis of 35 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
Trupti Wadekar
Assistant Manager,
Market Research & Consulting

Trupti is a senior consultant with over 10 years of experience in the Healthcare sector, specializing in pharmaceuticals, biotechnology, and life-sciences markets. She holds a Bachelor’s degree in Biotechnology and an MBA with dual specialization in Marketing and Pharmaceuticals & Biotechnology, combining a strong scientific foundation with a strategic and commercial perspective. Her professional experience encompasses market research, competitive intelligence, strategic advisory, and business development, supporting clients across diverse and evolving healthcare markets.

She has worked extensively on market sizing and assessment, growth strategy, market expansion, and strategic decision-making initiatives, helping clients identify opportunities and address complex business challenges. Trupti brings strong expertise in client engagement, stakeholder management, team leadership, and translating research findings into actionable business insights. Her ability to connect scientific understanding with market dynamics and commercial strategy enables her to deliver practical, high-impact solutions aligned with client objectives.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA